Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

ERG Intragenic Deletion Characterizes a Distinct Oncogenic Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with a Favourable Outcome Despite Frequent IKZF1 Deletions

Blood (2012) 120 (21): 121.

https://doi.org/10.1182/blood.V120.21.121.121

Published: 2012

Journal Articles

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Brigitte Nelken, MD, Guy Leverger, MD, Claire Galambrun, MD, Genevieve Plat, Claudine Schmitt, MD, Caroline Thomas, M.D., Cécile Vérité, MD, Benoit Brethon, MD, Virginie Gandemer, Yves Bertrand, André Baruchel, Pierre Rohrlich

Blood (2012) 120 (21): 2570.

https://doi.org/10.1182/blood.V120.21.2570.2570

Published: 2012

Journal Articles

Telomere Length and Telomerase Complex Mutations in Pediatric Acute Myeloid Leukemia

Anna M. Aalbers, Rodrigo T. Calado, Neal S. Young, Christian M. Zwaan, Colin O. Wu, Sachiko Kajigaya, PhD, Eva A. Coenen, André Baruchel, Karin Geleijns, Valerie de Haas, Gertjan J.L. Kaspers, MD, PhD, Taco W. Kuijpers, Dirk Reinhardt, MD, Jan Trka, MD, PhD, Martin Zimmermann, Rob Pieters, MD, PhD, Vincent H.J. van der Velden, Marry M. van den Heuvel-Eibrink

Blood (2012) 120 (21): 1482.

https://doi.org/10.1182/blood.V120.21.1482.1482

Published: 2012

Journal Articles

The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results

Frédéric Millot, Meinolf Suttorp, MD, Joelle Guilhot, Ph.D., Pietr Sedlacek, Evelina S De Bont, Chi Kong Li, MBBS, MD, Krzysztof Kalwak, Birgitte Lausen, Culic Srdjana, Marie-Françoise Dresse, Andrea Biondi, MD, André Baruchel

Blood (2012) 120 (21): 3741.

https://doi.org/10.1182/blood.V120.21.3741.3741

Published: 2012

Journal Articles

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

C. Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, Donna L Lancaster, MBChB, MRCPCH, Pamela R. Kearns, BSc, MBBCh, MRCP, PhD, Thomas Lehrnbecher, Vincent H. J. van der elden, H. Berna Beverloo, PhD, Monique L. den Boer, Rob Pieters, MD, PhD, Julie Rosenberg, Robert Herdlicka, Dominique Derreumaux, Shruti Agrawal, André Baruchel

Blood (2010) 116 (21): 2265.

https://doi.org/10.1182/blood.V116.21.2265.2265

Published: 2010

Journal Articles

A Recurrent Pattern of Acquired Genomic Abnormalities In Myelodysplasia and Leukemia of Fanconi Anemia Includes Cryptic RUNX1/AML1 abnormalities

Blood (2010) 116 (21): 975.

https://doi.org/10.1182/blood.V116.21.975.975

Published: 2010

Journal Articles

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Jean-Baptiste Micol, Emmanuel Raffoux, MD, Nicolas Boissel, MD, PhD, Etienne Lengliné, MD, Emmanuel Canet, Thierry Leblanc, Marie-Thérèse Daniel, Adrienne de Labarthe, Odile Maarek, Bruno Cassinat, Christine Chomienne, MD, PhD, Lionel Adès, André Baruchel, Laurent Degos, Elie Azoulay, MD, PhD, Hervé Dombret

Blood (2010) 116 (21): 1083.

https://doi.org/10.1182/blood.V116.21.1083.1083

Published: 2010

Journal Articles

CD4 T-Cell Response to Pandemic H1N1 Specific Vaccine After HSCT In Pediatric Recipients

Marie-Louise Frémond, Marie Duchamp, Valérie Guérin, Domitille Serraz, Frédérique Duquesne, Marie Ouachée-Chardin, André Baruchel, Ghislaine Sterkers, Jean-Hugues Dalle

Blood (2010) 116 (21): 2338.

https://doi.org/10.1182/blood.V116.21.2338.2338

Published: 2010

Journal Articles

A Pediatric Treatment of Ph-Negative Acute Lymphoblastic Leukemia (ALL) Is Effective and Safe In Adolescents and Young Adults (AYAs) until 29 Years of Age

Thomas Cluzeau, Nathalie Dhedin, Françoise Huguet, Emmanuel Raffoux, MD, Sebastien Maury, MD, Thierry Lamy, Lionel Mannone, Gaelle Guillerm, MD, Andre Delannoy, MD, Pascal Turlure, Norbert Vey, MD, André Baruchel, Herve Dombret, MD, PhD, Nicolas Boissel, MD, PhD

Blood (2010) 116 (21): 2125.

https://doi.org/10.1182/blood.V116.21.2125.2125

Published: 2010

Journal Articles

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

Moema Nene Santos, MD, Vanderson Rocha, MD, PhD, Dalila Zanette, Pharm, Raphael Porcher, MS, Irina Ionescu, MD, Marli Tavela, Tech, Jean Soulier, MD, PhD, Thierry Leblanc, MD, Gustavo Fisher, MD, André Baruchel, MD, Marco Antonio Zago, MD, Eliane Gluckman, MD

Blood (2005) 106 (11): 106.

https://doi.org/10.1182/blood.V106.11.106.106

Published: 2005

Journal Articles

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

André Baruchel, MD, Sylvie Chevret, MD, PhD, Anne Auvrignon, MD, Paola Ballerini, MD, PhD, Gérard Michel, MD, Jean Gabert, MD, PhD, Christiane Vermylen, MD, Yves Perel, MD, Chrystèle Bilhou-Nabera, MD, Odile Lejars, MD, Claudine Schmitt, MD, Pierre Jonveaux, MD, PhD, Jean Soulier, MD, PhD, Jacqueline Vandenaker, MD, Marie-Françoise Auclerc, MD, Thierry Leblanc, MD, Guy Leverger, MD, for the FRALLE Group

Blood (2005) 106 (11): 1441.

https://doi.org/10.1182/blood.V106.11.1441.1441

Published: 2005

Journal Articles

Cerebral Thromboses during Treatment of Childhood Acute Lymphoblastic Leukaemia.

Brigitte Pautard, Julie Micheli, Marie-Françoise Auclerc, Valérie Li Thiao Te, Thierry Leblanc, Barbara Horle, Judith Landman Parker, Claudine Schmitt, Gérard Michel, Pascale Schneider, Geneviève Margueritte, Anne Notz, Virginie Gandemer, Guy Leverger, André Baruchel

Blood (2005) 106 (11): 876.

https://doi.org/10.1182/blood.V106.11.876.876

Published: 2005

Journal Articles

HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)

Jean Soulier, Emmanuelle Clappier, Jean-Michel Cayuela, Armelle Regnault, Marina García-Peydró, Hervé Dombret, André Baruchel, Maria-Luisa Toribio, François Sigaux

Blood (2005) 106 (1): 274–286.

https://doi.org/10.1182/blood-2004-10-3900

Published: 2005

Includes: Supplemental data

Journal Articles

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway

Jean Soulier, Thierry Leblanc, Jérôme Larghero, Hélène Dastot, Akiko Shimamura, Philippe Guardiola, Hélène Esperou, Christèle Ferry, Charlotte Jubert, Jean-Paul Feugeas, Annie Henri, Antoine Toubert, Gérard Socié, André Baruchel, François Sigaux, Alan D. D'Andrea, Eliane Gluckman

Blood (2005) 105 (3): 1329–1336.

https://doi.org/10.1182/blood-2004-05-1852

Published: 2005

Journal Articles

Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

Laurent Garderet, Myriam Labopin, Norbert-Claude Gorin, Emmanuelle Polge, André Baruchel, Giovanna Meloni, Juan Ortega, Jaak Vossen, Donald Bunjes, Guy Leverger, Didier Blaise, Augustin Ferrant, Mats Brune, Eric Dore, Helmut Gadner, Felix Zintl, Isaac Yaniv, Giorgio Dini, Francesco Frassoni

Blood (2005) 105 (1): 405–409.

https://doi.org/10.1182/blood-2004-03-1103

Published: 2005

Journal Articles

Intermediate Dose Methotrexate in Low-Risk Acute Lymphoblastic Leukemia. Results of the FRALLE 93A Protocol.

Yves Perel, Hervé Chambost, Virginie Gandemer, Thierry Leblanc, Schneider Pascale, Schmitt Claudine, Mariane Debré, Christiane Vermylen, Gérard Couillault, Jean-Paul Lamagnere, Marie-Françoise Auclerd, Guy Leverger, André Baruchel, the FRALLE group

Blood (2004) 104 (11): 1949.

https://doi.org/10.1182/blood.V104.11.1949.1949

Published: 2004

Journal Articles

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Blood (2004) 104 (11): 1105.

https://doi.org/10.1182/blood.V104.11.1105.1105

Published: 2004

NARROW

ERG Intragenic Deletion Characterizes a Distinct Oncogenic Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with a Favourable Outcome Despite Frequent IKZF1 Deletions

Safety of Clofarabine with Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (Vandevol study of the French SFCE Acute Leukemia Committee).

Telomere Length and Telomerase Complex Mutations in Pediatric Acute Myeloid Leukemia

The International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped-Study): Objectives and Preliminary Results

Dasatinib In Children and Adolescents with Relapsed or Refractory Leukemia: Results of the CA180018 Phase 1 Dose-Escalation Study of the Innovative Therapies for Children with Cancer (ITCC) Consortium

A Recurrent Pattern of Acquired Genomic Abnormalities In Myelodysplasia and Leukemia of Fanconi Anemia Includes Cryptic RUNX1/AML1 abnormalities

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

CD4 T-Cell Response to Pandemic H1N1 Specific Vaccine After HSCT In Pediatric Recipients

A Pediatric Treatment of Ph-Negative Acute Lymphoblastic Leukemia (ALL) Is Effective and Safe In Adolescents and Young Adults (AYAs) until 29 Years of Age

Different Prevalence of Drug Metabolism Gene Polymorphisms (GSTP and GSTT) in FA Patients Compared to a Normal Population.

A Plateau after 30 Months of Follow-Up in B -Lineage Childhood Acute Lymphoblastic Leukemia (ALL) with t(1;19)(q23;p13)/E2A-PBX1?.

Cerebral Thromboses during Treatment of Childhood Acute Lymphoblastic Leukaemia.

HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)

Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway

Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

Intermediate Dose Methotrexate in Low-Risk Acute Lymphoblastic Leukemia. Results of the FRALLE 93A Protocol.

Minimal Residual Disease (MRD) at the End of Induction (EOI) after a Three or Four-Drug Induction Regimen for Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): Interim Results of the FRALLE 2000-A Protocol.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only